PRX IV Inhibitors
PRX IV inhibitors, as described in the context of the above table, represent a diverse group of chemicals that influence the activity of PRX IV indirectly by affecting related cellular pathways or processes. These chemicals do not inhibit PRX IV directly but modulate the enzyme's activity through changes in the cellular redox environment or by impacting the availability of its substrates or cofactors. The first method by which these chemicals can influence PRX IV involves altering the cellular redox balance. Compounds such as Auranofin, Cisplatin, Arsenic Trioxide, Buthionine Sulfoximine, and 2-AAPA impact the cellular redox environment either by inhibiting enzymes crucial for maintaining redox homeostasis or by inducing oxidative stress. For instance, Auranofin inhibits thioredoxin reductase, an enzyme vital for regenerating peroxiredoxins, including PRX IV. By inhibiting TrxR, Auranofin could hinder the regeneration of PRX IV, thus indirectly inhibiting its activity. Similarly, agents like Cisplatin and Arsenic Trioxide induce oxidative stress, overloading PRX IV's capacity to reduce hydrogen peroxide, and thereby functionally inhibiting it.
Another method involves the use of antioxidants or compounds that modulate oxidative stress levels. Chemicals like DPI, Mito-TEMPO, N-acetylcysteine, Vitamin E, and Curcumin alter the generation, scavenging, or balance of reactive oxygen species (ROS) within cells. By modulating ROS levels, these compounds can indirectly influence the functional demand on PRX IV. For instance, antioxidants such as N-acetylcysteine and Vitamin E can scavenge free radicals, reducing the workload on PRX IV and thereby diminishing its role in mitigating oxidative stress. DPI, by inhibiting ROS-generating enzymes, can decrease the oxidative burden on cells, indirectly affecting the necessity for PRX IV activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Auranofin | 34031-32-8 | sc-202476 sc-202476A sc-202476B | 25 mg 100 mg 2 g | $153.00 $214.00 $4000.00 | 39 | |
Auranofin is a gold-containing compound known to inhibit thioredoxin reductase (TrxR). Since TrxR is involved in the reduction of peroxiredoxins, including PRX IV, inhibition of TrxR by Auranofin could indirectly inhibit the regeneration of PRX IV, thus reducing its activity. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin, a platinum-based chemotherapy drug, can induce oxidative stress in cells. Increased oxidative stress might overload the PRX IV enzymatic capacity, indirectly inhibiting its function due to excessive substrate (hydrogen peroxide) levels. | ||||||
Arsenic(III) oxide | 1327-53-3 | sc-210837 sc-210837A | 250 g 1 kg | $89.00 $228.00 | ||
Arsenic Trioxide, studied in the research of acute promyelocytic leukemia, can induce oxidative stress. The increased oxidative burden may indirectly inhibit PRX IV by overwhelming its antioxidant capacity. | ||||||
L-Buthionine sulfoximine | 83730-53-4 | sc-200824 sc-200824A sc-200824B sc-200824C | 500 mg 1 g 5 g 10 g | $286.00 $442.00 $1532.00 $2975.00 | 26 | |
Buthionine Sulfoximine inhibits glutathione synthesis. Reduced glutathione levels can lead to increased oxidative stress, potentially overwhelming PRX IV’s antioxidant activity. | ||||||
Mito-TEMPO | 1569257-94-8 | sc-221945 sc-221945A | 5 mg 25 mg | $66.00 $255.00 | 136 | |
Mito-TEMPO is a mitochondria-targeted antioxidant. It reduces mitochondrial ROS, potentially altering the redox environment and indirectly influencing PRX IV activity. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram, studied in the research of alcohol dependence, can modulate cellular redox status by inhibiting aldehyde dehydrogenase and other enzymes. This modulation might indirectly affect PRX IV activity. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
N-acetylcysteine, a precursor to glutathione, can alter the cellular redox balance. By increasing reduced glutathione levels, it might indirectly influence PRX IV activity by altering the cellular redox environment. | ||||||
DL-α-Tocopherol | 10191-41-0 | sc-294383 sc-294383A sc-294383B sc-294383C | 5 g 25 g 100 g 500 g | $26.00 $52.00 $124.00 $326.00 | 3 | |
DL-α-Tocopherol is an antioxidant that can scavenge free radicals and reduce oxidative stress. This reduction in oxidative stress might indirectly affect PRX IV activity by altering the need for PRX IV-mediated hydrogen peroxide reduction. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin, a polyphenol, has antioxidant properties and can modulate various signaling pathways. It might indirectly influence PRX IV activity by altering cellular redox status and signaling pathways that impact oxidative stress levels. | ||||||